![Andrew Cunningham](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Andrew Cunningham
Directeur Technique/Scientifique/R&D chez CALCIMEDICA, INC.
Relations actives
Nom | Sexe | Age | Sociétés liées | Collaboration |
---|---|---|---|---|
Michael Dunn | M | 68 | 10 ans | |
Rachel Leheny | M | 60 | 5 ans | |
Allan Shaw | M | 59 | 1 ans | |
Robert Wilson | M | 83 | 1 ans | |
Fred Middleton | M | 74 | 4 ans | |
Eric Bjerkholt | M | 64 | 1 ans | |
Eric Roberts | M | 59 | 4 ans | |
Kenneth Stauderman | M | 71 | 17 ans | |
Sudarshan Hebbar | M | 59 | 9 ans | |
Daniel Geffken | M | 67 | 1 ans | |
John Dunn | M | 72 | 1 ans | |
Mary Newman | F | 65 | 3 ans | |
Frédéric Guerard | M | 51 | 1 ans | |
Raven Jaeger | F | 46 | 1 ans |
Graphique Relationnel
Relation dans plusieurs entreprises
Anciennes relations
Nom | Sexe | Age | Sociétés liées | Collaboration |
---|---|---|---|---|
Manmeet Singh Soni | M | 46 | 4 ans | |
Martin Edwards | M | 68 | 3 ans | |
James E. Bass | M | 65 | 6 ans | |
Claire Aldridge | M | - | 1 ans | |
James Kehoe | M | 60 | 2 ans | |
Rolando Gutíerrez-Esteinou | M | 63 | 1 ans | |
Richard A. Moscicki | M | 72 |
Genzyme Therapeutics Ltd.
![]() Genzyme Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Genzyme Therapeutics Ltd. develops transformative therapies for patients affected by rare and debilitating diseases. Its treatment areas include thyroid cancer, sclerosis, Fabry disease and Pompe. The company was founded on November 5, 2001 and is headquartered in Oxford, the United Kingdom. | 2 ans |
Oscar Sanchez | M | - | 2 ans | |
Dakota Gallivan | M | - | 3 ans | |
Kleem Chaudhary | M | 48 | 2 ans | |
Steve Harman | M | - | 4 ans | |
Sigurd Okkels | M | - | 6 ans | |
Keith Ward | M | 54 | 8 ans | |
Andrew Michael James Prosser | M | - |
Genzyme Therapeutics Ltd.
![]() Genzyme Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Genzyme Therapeutics Ltd. develops transformative therapies for patients affected by rare and debilitating diseases. Its treatment areas include thyroid cancer, sclerosis, Fabry disease and Pompe. The company was founded on November 5, 2001 and is headquartered in Oxford, the United Kingdom. | - |
Samina Khan | M | 59 | 3 ans | |
Kevin Johnston | M | - | 2 ans | |
Peter DiLaura | M | - | - | |
Geoffrey A. Block | M | 58 | - | |
Andrea Loewen-Rodriguez | F | 57 | 3 ans | |
Padma Thiruvengadam | F | 59 | - | |
Emil Chuang | M | 64 | 2 ans |
Statistiques
Pays | Relations | % du total |
---|---|---|
Etats-Unis | 26 | 74,29% |
Japon | 7 | 20,00% |
Royaume-Uni | 2 | 5,71% |
Age des relations
Actives
Passées
Homme
Femme
Administrateurs
Exécutifs
Provenance des relations
- Bourse
- Insiders
- Andrew Cunningham
- Réseau Personnel